Sponsor

Tanox

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Tanox appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1NCT00089700 · lead sponsor · 2004-03-01
UNKNOWN
A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE LevelsNCT00624832 · collaborator · 2008-02-01
COMPLETED
Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.NCT00500539 · collaborator · 2007-07-01
COMPLETED
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic AsthmaNCT00267202 · collaborator · 2005-12-01
COMPLETED
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic AsthmaNCT00264849 · collaborator · 2005-11-01
COMPLETED

Sponsor roles

collaborator4
lead sponsor1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.